Cargando…

Effect of systemic arterial hypertension and use of antiproteinuric drug in induction therapy for lupus nephritis

OBJECTIVE: To evaluate the therapeutic response to induction treatment in lupus nephritis patients. METHODS: A total of 29 patients diagnosed with systemic lupus erythematosus and biopsy-proven nephritis were divided into two groups, one with hypertensive individuals and another non-hypertensive pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matta, Eduardo Grecco, Rubini, Danielle Arraes, Araújo, Nafice Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453831/ https://www.ncbi.nlm.nih.gov/pubmed/36083852 http://dx.doi.org/10.31744/einstein_journal/2020AO5322

Ejemplares similares

Efficacy and safety of tacrolimus in induction therapy of patients with lupus nephritis
por: Zhou, Tianbiao, et al.
Publicado: (2019)

Antiproteinuric and Hyperkalemic Mechanisms Activated by Dual Versus Single Blockade of the RAS in Renovascular Hypertensive Rats
por: Corrêa, José Wilson N., et al.
Publicado: (2021)

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis
por: Tian, Ming, et al.
Publicado: (2017)

Urine biomarker score captures response to induction therapy with lupus nephritis
por: Cody, Ellen M., et al.
Publicado: (2023)

Is the Antiproteinuric Effect of Cyclosporine A Independent of Its Immunosuppressive Function in T Cells?
por: Zhang, Bin, et al.
Publicado: (2012)

Antiproteinuric therapy and Fabry nephropathy: factors associated with preserved kidney function during agalsidase-beta therapy
por: Warnock, David G, et al.
Publicado: (2015)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Evaluation of antiproteinuric and hepato-renal protective activities of propolis in paracetamol toxicity in rats
por: El Menyiy, Nawal, et al.
Publicado: (2018)

Rituximab alone as induction therapy for membranous lupus nephritis: A multicenter retrospective study
por: Chavarot, Nathalie, et al.
Publicado: (2017)

Iguratimod as an alternative induction therapy for refractory lupus nephritis: a preliminary investigational study
por: Kang, Yuening, et al.
Publicado: (2020)

Intracranial hypertension: A rare presentation of lupus nephritis
por: Yadav, Praveen, et al.
Publicado: (2010)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
por: Nie, Huiyu, et al.
Publicado: (2023)

Comparing the Efficacy and Safety of Induction Therapies for the Treatment of Patients with Proliferative Lupus Nephritis in South Africa
por: Sogayise, Phelisa, et al.
Publicado: (2020)

Tacrolimus Induction Therapy for Nephrotic Syndrome Caused by Minimal Mesangial Lupus Nephritis with Lupus Podocytopathy: A Case-Based Review
por: Kurihara, Ibuki, et al.
Publicado: (2022)

Targeting Regulatory T Cells for Therapy of Lupus Nephritis
por: Venkatadri, Rajkumar, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Amiloride as an Alternate Adjuvant Antiproteinuric Agent in Fabry Disease: The Potential Roles of Plasmin and uPAR
por: Trimarchi, H., et al.
Publicado: (2014)

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
por: Advani, Andrew, et al.
Publicado: (2013)

Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease
por: Capelli, Irene, et al.
Publicado: (2023)

Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)

Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses
por: Shin, Jae Il, et al.
Publicado: (2022)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

The outcome of proliferative lupus nephritis with pulse cyclophosphamide therapy
por: Annavarajula, S. K., et al.
Publicado: (2011)

Eculizumab as rescue therapy in severe resistant lupus nephritis
por: Pickering, Matthew C., et al.
Publicado: (2015)

The history of pulse therapy in lupus nephritis (1976–2016)
por: Scheinberg, Morton
Publicado: (2016)

Expanding the Role of Complement Therapies: The Case for Lupus Nephritis
por: Li, Nicholas L., et al.
Publicado: (2021)

Zebra bodies in lupus nephritis after hydroxychloroquine therapy
por: Singh, Anshima, et al.
Publicado: (2023)

Paricalcitol as an Antiproteinuric Agent Can Result in the Deterioration of Renal and Heart Function in a Patient with Fabry Disease
por: Keber, Tajda, et al.
Publicado: (2017)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Serum Axl predicts histology-based response to induction therapy and long-term renal outcome in lupus nephritis
por: Parodis, Ioannis, et al.
Publicado: (2019)

Urine neutrophil gelatinase-associated lipocalin to predict renal response after induction therapy in active lupus nephritis
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Comparative Effectiveness of Rituximab and Common Induction Therapies for Lupus Nephritis: A Systematic Review and Network Meta-Analysis
por: Li, Kang, et al.
Publicado: (2022)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

The Use of Glucocorticoids in Lupus Nephritis: New Pathways for an Old Drug
por: Mejía-Vilet, Juan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_84v7amijvdjs744vm59m3f2mjp